Cargando…

Nitric oxide therapy in persistent pulmonary hypertension of the newborns (PPHN): predictors of survival in a single center experience

Detalles Bibliográficos
Autores principales:	Maruniak-Chudek, I, Wiecek-Wlodarska, D, Świetliński, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301606/ http://dx.doi.org/10.1186/cc2050

Ejemplares similares

Echocardiographic Parameters Predictive of Poor Outcome in Persistent Pulmonary Hypertension of the Newborn (PPHN): Preliminary Results
por: Breinig, Sophie, et al.
Publicado: (2021)

Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN)
por: Vijay Kumar, J.R., et al.
Publicado: (2021)

Factors influencing serum lactate concentration in ICU newborns
por: Maruniak-Chudek, I, et al.
Publicado: (1998)

Asphyxia and Neonatal Respiratory Distress Syndrome Are Independent Predictors of the Non-response to Inhaled Nitric Oxide in the Newborns With PPHN
por: Zhao, Yuwei, et al.
Publicado: (2021)

Altered hypoxia‐inducible factor–1α (HIF‐1α) signaling contributes to impaired angiogenesis in fetal lambs with persistent pulmonary hypertension of the newborn (PPHN)
por: Makker, Kartikeya, et al.
Publicado: (2019)

Successful Weaning From Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) After Initiation of Inhaled Epoprostenol in a Neonate With Refractory Persistent Pulmonary Hypertension of the Newborn (PPHN)
por: Shehzad, Irfan, et al.
Publicado: (2023)

Life-threatening PPHN refractory to nitric oxide: proposal for a rational therapeutic algorithm
por: Fortas, Feriel, et al.
Publicado: (2021)

Clinical response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn.
por: Ko, S. Y., et al.
Publicado: (1998)

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn refractory to high-frequency ventilation
por: Al-Alaiyan, Saleh, et al.
Publicado: (1999)

Black lung persistent pulmonary hypertension of the newborn: Saudi experience with sildenafil and nitric oxide
por: Alnemri, AbdulRahman M.
Publicado: (2017)

Persistent pulmonary hypertension of the newborn
por: Sharma, Vinay, et al.
Publicado: (2015)

Persistent Pulmonary Hypertension in the Newborn
por: Mathew, Bobby, et al.
Publicado: (2017)

Hypoxia and hyperoxia potentiate PAF receptor‐mediated effects in newborn ovine pulmonary arterial smooth muscle cells: significance in oxygen therapy of PPHN
por: Hanouni, Mona, et al.
Publicado: (2016)

Zonulin: A Potential Marker of Intestine Injury in Newborns
por: Tarko, Anna, et al.
Publicado: (2017)

Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response
por: Nelin, Leif D., et al.
Publicado: (2019)

Nitric oxide improves pulmonary vascular resistance but not oxygenation in ARDS, heart transplant, and pulmonary hypertension
por: DaSilva, MC, et al.
Publicado: (1998)

Patient Characteristics in Persistent Pulmonary Hypertension of the Newborn
por: Roofthooft, M. T. R., et al.
Publicado: (2011)

Risk factors for persistent pulmonary hypertension of the newborn
por: Delaney, Cassidy, et al.
Publicado: (2012)

Altered metabolites in newborns with persistent pulmonary hypertension
por: Steurer, Martina A., et al.
Publicado: (2018)

Serum and Urinary NGAL in Septic Newborns
por: Smertka, Mike, et al.
Publicado: (2014)

Postnatal causes and severity of persistent pulmonary Hypertension of Newborn
por: Arshad, Muhammad Sohail, et al.
Publicado: (2021)

Diastolic ventricular function in persistent pulmonary hypertension of the newborn
por: Le Duc, Kévin, et al.
Publicado: (2023)

Survival and associated risk factors for mortality among infants with persistent pulmonary hypertension of the newborn in Malaysia
por: Mat Bah, Mohd Nizam, et al.
Publicado: (2021)

Correlation of ABO blood groups with treatment response and efficacy in infants with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide
por: Guan, Yi, et al.
Publicado: (2023)

Maternal tobacco smoke exposure and persistent pulmonary hypertension of the newborn.
por: Bearer, C, et al.
Publicado: (1997)

Risk factors and mortality among newborns with persistent pulmonary hypertension
por: Razzaq, Athar, et al.
Publicado: (2013)

The Use of Supplemental Hydrocortisone in the Management of Persistent Pulmonary Hypertension of the Newborn
por: Aleem, Samia, et al.
Publicado: (2021)

Inhaled nitric oxide in postpneumonectomy pulmonary edema
por: Keegan, MT, et al.
Publicado: (2003)

Hypoxia inducible factor signaling and experimental persistent pulmonary hypertension of the newborn
por: Wedgwood, Stephen, et al.
Publicado: (2015)

Persistent Pulmonary Hypertension of the Newborn: Pathophysiological Mechanisms and Novel Therapeutic Approaches
por: Martinho, Sofia, et al.
Publicado: (2020)

Frequent mutation of hypoxia-related genes in persistent pulmonary hypertension of the newborn
por: Wang, Mingbang, et al.
Publicado: (2020)

A Meta-Analysis of the Risk Factors of Persistent Pulmonary Hypertension in Newborns
por: Zhou, Ran, et al.
Publicado: (2021)

Utility of Nebulized Magnesium Sulfate Therapy for Persistent Pulmonary Hypertension of Newborn
por: Bethou, Adhisivam
Publicado: (2021)

Use of vasopressin in persistent pulmonary hypertension of the newborn: A case series
por: Joshi, Swosti, et al.
Publicado: (2022)

Inhaled iloprost is an effective alternative therapy for persistent pulmonary hypertension in newborns
por: Yıldırım, Şükran
Publicado: (2023)

Persistence of persistent pulmonary hypertension of the newborn: A case of de novo TBX4 variant
por: Tsoi, Stephanie M., et al.
Publicado: (2022)

Endotoxin-induced pulmonary hyporesponsiveness to inhaled nitric oxide is improved by nitric oxide synthase 2 inhibition
por: Bopp, C, et al.
Publicado: (2000)

Novel scoring tool of hypoxemic respiratory failure and pulmonary hypertension for defining severity of persistent pulmonary hypertension of newborn
por: Timberline, Sage, et al.
Publicado: (2023)

Pathophysiology, Management, and Outcome of Persistent Pulmonary Hypertension of the Newborn: A Clinical Review
por: Puthiyachirakkal, Mohammed, et al.
Publicado: (2013)

Altered Prostanoid Metabolism Contributes to Impaired Angiogenesis in Persistent Pulmonary Hypertension of the Newborn
por: Mahajan, Chaitali N., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0aoispneckk603fppekfur2lb8